Guardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024. In the quarter to June 2026, revenue grew 44.3%, EPS fell 12.5%, free cash flow fell 5.46% and total debt rose 34.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow GH
Guardant Health, Inc. (GH) Altman Z-score
Guardant Health, Inc.'s Altman Z-score for fiscal 2025 is 2.02, in the grey zone (1.81–2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 2.02 | 2.88 |
| FY2024 | −0.86 | (0.34) |
| FY2023 | −0.52 | (0.06) |
| FY2022 | −0.46 | (3.78) |
| FY2021 | 3.31 | (4.78) |
| FY2020 | 8.09 | (17.87) |
| FY2019 | 25.96 | 19.56 |
| FY2018 | 6.40 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.58 | — | 0.69 | |
| Retained earnings / total assets | (1.49) | — | −2.08 | |
| EBIT / total assets | (0.22) | — | −0.72 | |
| Market value of equity / total liabilities | 6.06 | — | 3.64 | |
| Sales / total assets | 0.49 | — | 0.49 | |
| Altman Z-score | Grey zone | 2.02 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −2.57 | ||
Z and Z″ put Guardant Health, Inc. in different zones: grey zone by Z, distress zone by Z″.
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| MTD Mettler-Toledo International, Inc. compare | 10.2× |
| MEDP Medpace Holdings, Inc. compare | 8.0× |
| ILMN Illumina, Inc. compare | 4.4× |
| DGX Quest Diagnostics Incorporated compare | 3.1× |
| LH Labcorp Holdings Inc. compare | 3.0× |
| RVTY Revvity Inc. compare | 2.5× |
| CRL Charles River Laboratories International, Inc. compare | 2.4× |
| GH Guardant Health, Inc. | 2.0× |
| ICLR ICON PLC compare | 2.0× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets